Perioperative effects of high doses of intraoperative thymoglobulin induction in liver transplantation

Table 3 Haemodynamic variable measurements made in both groups during the different phases of liver transplantation and on post-op days 1 and 2

Phases of liver transplantation and post-op days 1 and 2	Groups	MAP		CI		SVRI		RVEDVI
		mmHg	P	L/min per square meter	P	dyne/s/cm5 per square meter	P	mL/m2	P
Basal	ATG	75 ± 10	0.18	5.1 ± 3.5	0.91	1100 ± 215	0.31	219 ± 75	0.12
	Control	70 ± 8		4.9 ± 2.8		1150 ± 324		222 ± 58
Laparotomy	ATG	67 ± 24	0.16	5.7 ± 3.4	0.41	730 ± 337	< 0.01	259 ± 120	0.21
	Control	70 ± 31		5.8 ± 2		1235 ± 488		262 ± 98
Pre-anhepatic	ATG	52 ± 19	< 0.01	6.5 ± 2.9	0.3	540 ± 188	< 0.01	340 ± 99	0.65
	Control	69 ± 25		5.9 ± 3.1		1145 ± 338		300 ± 78
Anhepatic	ATG	68 ± 12	0.16	7.5 ± 3.6	0.69	598 ± 213	< 0.01	335 ± 98	0.61
	Control	73 ± 23		6.3 ± 3.9		988 ± 238		308 ± 115
30’ post-reperfusion	ATG	48 ± 24	0.04	7.1 ± 3.1	0.7	510 ± 343	< 0.05	368 ± 75	0.63
	Control	59 ± 31		6.6 ± 3.8		855 ± 417		355 ± 58
60’ post-reperfusion	ATG	47 ± 33	< 0.01	7.2 ± 4.1	0.61	521 ± 243	< 0.001	300 ± 100	0.78
	Control	66 ± 28		6.6 ± 3.8		945 ± 301		289 ± 125
120’ post-reperfusion	ATG	55 ± 38	0.07	7.6 ± 4.3	0.04	788 ± 306	0.06	345 ± 107	0.005
	Control	65 ± 23		5.9 ± 3.8		1100 ± 398		268 ± 99
POD1	ATG	60 ± 32	< 0.05	6.8 ± 4.1	0.51	795 ± 341	0.01	305 ± 106	0.01
	Control	71 ± 40		6 ± 3.5		1100 ± 287		233 ± 102
POD2	ATG	67 ± 26	0.15	6.1 ± 2.5	0.43	1130 ± 438	< 0.08	238 ± 143	0.33

MAP: Mean arterial pressure; CI: Cardiac index; SVRI: Systemic vascular resistance index; RVEDVI: Right ventricle end-diastolic volume index; ATG: Antithymocyte globulin; POD: Postoperative day.